For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

We use cookies to make our site as useful as possible.

Our Cookie Policy explains how you can opt-out of the cookies we use.

If you continue without changing your cookie settings, we'll assume you’re happy with this.

Continue Continue

United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Diagnostic & Therapeutic Solutions
    Custom solutions & partnerships

    Custom antibody development and commercial partnerships to advance your diagnostic and therapeutic discovery.

    Create custom solutions with us

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

  1. Link

    nada-n-arachidonyldopamine-endogenous-cb1--trpv1-agonist-ab120099.pdf

  1. Send me a copy of this email
    I agree to the terms and conditions.
Neuroscience Neurotransmission Receptors / Channels GPCR Cannabinoid Receptor
Share by email

NADA (N-Arachidonyldopamine), endogenous CB1 / TRPV1 agonist (ab120099)

  • Datasheet
  • SDS
  • COA
Submit a review Submit a question References (1)

Product price, shipping and contact information

Currently unavailable

Sorry, we can't display this right now.

Please contact us to place your order, or try again later.

 

Loading size & price…

 

Shipping and order information

Abpromise

Guaranteed product quality, expert customer support.

Find out more.

Functional Studies - NADA (N-Arachidonyldopamine), endogenous CB<sub>1</sub> / TRPV1 agonist (ab120099)

    Key features and details

    • Endogenous CB1 / TRPV1 agonist
    • CAS Number: 199875-69-9
    • Purity: > 98%
    • Supplied in ethanol (5 mg/ml)
    • Form / State: Liquid
    • Source: Synthetic

    Overview

    • Product name

      NADA (N-Arachidonyldopamine), endogenous CB1 / TRPV1 agonist
    • Description

      Endogenous CB1 / TRPV1 agonist
    • Alternative names

      • N-Arachidonyldopamine
    • Biological description

      Potent endogenous cannabinoid and vanilloid receptor agonist. (Ki values are 0.25 and 12 μM for CB1 and CB2, respectively). Potent agonist at TRPV1 (VR1) receptors (EC50 = ~50 nM). Active in vivo.

    • Purity

      > 98%
    • CAS Number

      199875-69-9
    • Chemical structure

      Chemical Structure

    Properties

    • Chemical name

      (5Z,8Z,11Z,14Z)-N-(3,5-dihydroxyphenethyl)icosa-5,8,11,14-tetraenamide
    • Molecular weight

      439.63
    • Molecular formula

      C28H41NO3
    • PubChem identifier

      5282105
    • Storage instructions

      Store at -20°C (desiccating conditions).
    • Solubility overview

      Supplied in ethanol (5 mg/ml)
    • Handling

      Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 6 months. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

      Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

    • SMILES

      Oc1ccc(CCNC(=O)CCC/C=CC/C=CC/C=CC/C=CCCCCC)cc1O
    • Source

      Synthetic

    • Research areas

      • Neuroscience
      • Neurotransmission
      • Receptors / Channels
      • GPCR
      • Cannabinoid Receptor
      • Epigenetics and Nuclear Signaling
      • Chromatin Modifying Enzymes
      • Acetylation
      • Cardiovascular
      • Lipids / Lipoproteins
      • Lipid Metabolism
      • Cholesterol Metabolism
      • Epigenetics and Nuclear Signaling
      • Transcription
      • Domain Families
      • Zinc Finger
      • Neuroscience
      • Neurotransmission
      • Receptors / Channels
      • More Ion Channels
      • Signal Transduction
      • Growth Factors/Hormones
      • Hormones
      • Neuroscience
      • Sensory System
      • Somatosensory system
      • Nociception
      • Epigenetics and Nuclear Signaling
      • Nuclear Signaling Pathways
      • Nuclear Receptors
      • Corticoid
      • Signal Transduction
      • Signaling Pathway
      • Nuclear Signaling
      • Nuclear Hormone Receptors
      • Vitamin D Receptor
      • Epigenetics and Nuclear Signaling
      • Nuclear Signaling Pathways
      • Nuclear Receptors
      • Vitamin D Receptor
      • Epigenetics and Nuclear Signaling
      • Transcription
      • Transcription Factors
      • Signal Transduction
      • Metabolism
      • Alcohol metabolism
      • Cancer
      • Signal transduction
      • Nuclear signaling
      • Nuclear hormone receptors
      • Other
      • Cardiovascular
      • Atherosclerosis
      • Lipoprotein metabolism
      • Biochemicals
      • Chemical Type
      • Biochemicals
      • Biochemicals
      • Chemical Type
      • Lipid
      • Biochemicals
      • Pharmacology
      • Receptors & Transporters
      • Cannabinoid
      • CB1
      • Biochemicals
      • Pharmacology
      • Ion Channels
      • TRP
      • Agonists
      • Biochemicals
      • Pharmacology
      • Receptors & Transporters
      • Cannabinoid
      • CB1
      • Agonists
      • Metabolism
      • Pathways and Processes
      • Metabolic signaling pathways
      • Lipid and lipoprotein metabolism
      • Cholesterol Metabolism
      • Metabolism
      • Pathways and Processes
      • Metabolic signaling pathways
      • Lipid and lipoprotein metabolism
      • Lipoprotein metabolism
      • Metabolism
      • Pathways and Processes
      • Metabolic signaling pathways
      • Alcohol metabolism
      • Metabolism
      • Types of disease
      • Heart disease
      • Biochemicals
      • Research Area
      • Addiction
      • Cannabinoid
      • CB1
      • Biochemicals
      • Research Area
      • Addiction
      • Cannabinoid
      • CB1
      • Agonists
      • Biochemicals
      • Research Area
      • Diabetes
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Heart disease
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Hypertension
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Obesity
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Obesity
      • Cannabinoid
      • CB1
      • Biochemicals
      • Research Area
      • Obesity
      • Cannabinoid
      • CB1
      • Agonists
      • Biochemicals
      • Research Area
      • Pain & inflammation
      • Cannabinoid
      • CB1
      • Biochemicals
      • Research Area
      • Pain & inflammation
      • Cannabinoid
      • CB1
      • Agonists
      • Biochemicals
      • Research Area
      • Pain & inflammation
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Respiratory disease
      • TRP
      • Agonists
      • Biochemicals
      • Research Area
      • Stroke
      • TRP
      • Agonists
      • Biochemicals
      • Chemical Type
      • Controlled substances

    Applications

    Our Abpromise guarantee covers the use of ab120099 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Abreviews Notes
    Functional Studies Use at an assay dependent concentration.

    Images

    • Functional Studies - NADA (N-Arachidonyldopamine), endogenous CB<sub>1</sub> / TRPV1 agonist (ab120099)
      Functional Studies - NADA (N-Arachidonyldopamine), endogenous CB1 / TRPV1 agonist (ab120099)
      ab15580 staining Ki67 in SK-N-SH cells treated with NADA (N-Arachidonyldopamine) (ab120099), by ICC/IF. Decrease in Ki67 expression correlates with increased concentration of NADA (N-Arachidonyldopamine), as described in literature.
      The cells were incubated at 37°C for 10 minutes in media containing different concentrations of ab120099 (NADA (N-Arachidonyldopamine)) in ethanol, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab15580 (1 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

    Protocols

    To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

    Click here to view the general protocols

    Datasheets and documents

    • Datasheet
    • SDS
    • COA
  • References (1)

    Publishing research using ab120099? Please let us know so that we can cite the reference in this datasheet.

    ab120099 has been referenced in 1 publication.

    • Ferreira SG  et al. N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. Neuropharmacology 56:676-83 (2009). PubMed: 19101577

    Customer reviews and Q&As

    Show All Reviews Q&A
    Submit a review Submit a question

    There are currently no Customer reviews or Questions for ab120099.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
    For licensing inquiries, please contact partnerships@abcam.com

    Get resources and offers direct to your inbox Sign up
    A-Z by research area
    • Cancer
    • Cardiovascular
    • Cell biology
    • Developmental biology
    • Epigenetics & Nuclear signaling
    • Immunology
    • Metabolism
    • Microbiology
    • Neuroscience
    • Signal transduction
    • Stem cells
    A-Z by product type
    • Primary antibodies
    • Secondary antibodies
    • Biochemicals
    • Isotype controls
    • Flow cytometry multi-color selector
    • Kits
    • Loading controls
    • Lysates
    • Peptides
    • Proteins
    • Slides
    • Tags and cell markers
    • Tools & Reagents
    Help & support
    • Support
    • Make an Inquiry
    • Protocols & troubleshooting
    • Placing an order
    • RabMAb products
    • Biochemical product FAQs
    • Training
    • Browse by Target
    Company
    • Corporate site
    • Investor relations
    • Company news
    • Careers
    • About us
    • Blog
    Events
    • Tradeshows
    • Conferences
    International websites
    • abcam.cn
    • abcam.co.jp

    Join with us

    • LinkedIn
    • facebook
    • Twitter
    • YouTube
    • Terms of sale
    • Website terms of use
    • Cookie policy
    • Privacy policy
    • Legal
    • Modern slavery statement
    © 1998-2021 Abcam plc. All rights reserved.